MX9200725A - Tratamiento de cancer esofagico. tratamiento de cancer esofagico. - Google Patents

Tratamiento de cancer esofagico. tratamiento de cancer esofagico.

Info

Publication number: MX9200725A
Authority: MX; Mexico
Prior art keywords: cancer treatment; esophageal cancer; esophageal; treatment; cancer
Prior art date: 1991-02-21

Application number

MX9200725A

Other languages

English (en)

Inventor

Randall Keith Johnson Johnson

Original Assignee

Smithkline Beecham Corp Smithk

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-02-21

Filing date

1992-02-21

Publication date

1992-09-01

1992-02-21 Application filed by Smithkline Beecham Corp Smithk filed Critical Smithkline Beecham Corp Smithk

1992-09-01 Publication of MX9200725A publication Critical patent/MX9200725A/es

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

MX9200725A 1991-02-21 1992-02-21 Tratamiento de cancer esofagico. tratamiento de cancer esofagico. MX9200725A (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US65893691A	1991-02-21	1991-02-21

Publications (1)

Publication Number	Publication Date
MX9200725A true MX9200725A (es)	1992-09-01

Family

ID=24643326

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MX9200725A MX9200725A (es)	1991-02-21	1992-02-21	Tratamiento de cancer esofagico. tratamiento de cancer esofagico.

Country Status (8)

Country	Link
EP (1)	EP0572563A4 (es)
JP (1)	JPH06505487A (es)
KR (1)	KR930702985A (es)
AU (1)	AU664172B2 (es)
CA (1)	CA2104449A1 (es)
MX (1)	MX9200725A (es)
PT (1)	PT100154A (es)
WO (1)	WO1992014470A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6395541B1 (en)	1996-05-23	2002-05-28	The Rockefeller University	Methods for the identification of compounds capable of inhibiting HIV-1 viral replication employing murine cell lines expressing human topoisomerase I
AU2001243515A1 (en)	2000-03-08	2001-09-17	Rhode Island Hospital, A Lifespan Partner	Combination drug therapy
US20010039016A1 (en)	2000-03-27	2001-11-08	Waldman Scott A.	Use of expression profiling for identifying molecular markers useful for diagnosis of metastatic cancer
CN101273144B (zh) *	2005-07-27	2011-12-28	肿瘤疗法科学股份有限公司	诊断食道癌的方法
ES2371171B1 (es) *	2010-06-08	2012-11-16	Consejo Superior De Investigaciones Científicas (Csic)	Derivados de camptotecina como agentes antitumorales.
CN102659800B (zh) *	2012-05-11	2014-09-03	中国药科大学	一类低氧激活抗肿瘤化合物及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5004758A (en) *	1987-12-01	1991-04-02	Smithkline Beecham Corporation	Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells

1992
- 1992-02-07 AU AU15406/92A patent/AU664172B2/en not_active Ceased
- 1992-02-07 EP EP19920908199 patent/EP0572563A4/en not_active Withdrawn
- 1992-02-07 CA CA002104449A patent/CA2104449A1/en not_active Abandoned
- 1992-02-07 JP JP4507807A patent/JPH06505487A/ja active Pending
- 1992-02-07 KR KR1019930702492A patent/KR930702985A/ko not_active Ceased
- 1992-02-07 WO PCT/US1992/001029 patent/WO1992014470A1/en not_active Ceased
- 1992-02-21 PT PT100154A patent/PT100154A/pt not_active Application Discontinuation
- 1992-02-21 MX MX9200725A patent/MX9200725A/es unknown

Also Published As

Publication number	Publication date
JPH06505487A (ja)	1994-06-23
AU1540692A (en)	1992-09-15
CA2104449A1 (en)	1992-08-22
KR930702985A (ko)	1993-11-29
EP0572563A4 (en)	1993-12-29
EP0572563A1 (en)	1993-12-08
PT100154A (pt)	1993-05-31
AU664172B2 (en)	1995-11-09
WO1992014470A1 (en)	1992-09-03

Publication	Publication Date	Title
DE59102292D1 (de)	1994-08-25	Katheter.
MX9202978A (es)	1993-02-01	Compuestos de amino-4-aril-tiazoles.
FI920152A0 (fi)	1992-01-14	Kirurgisk borrschablon.
DE69203428D1 (de)	1995-08-17	Verbinder.
FI912348L (fi)	1991-11-16	Stabiliserad fgf sammansaettning.
MX9205172A (es)	1993-03-01	Genes de pinosilvinsintasa.
DE59203645D1 (de)	1995-10-19	Backofen.
DE69200956D1 (de)	1995-02-02	Panzerung.
NO911429D0 (no)	1991-04-11	Stoffbehandling.
DE69203171D1 (de)	1995-08-03	Verbinder.
NO912158D0 (no)	1991-06-05	Behandling av undergrunnsformasjon.
FI960658L (fi)	1996-02-14	Uudet bis-naftalimidit syövän hoitamiseksi
DE69112449D1 (de)	1995-10-05	Endoskop.
FR2680419B1 (fr)	1995-09-29	Endoscopes.
MX9202702A (es)	1992-12-01	Proceso de bioblanqueo.
DE69114853D1 (de)	1996-01-04	Abwasserbehandlung.
DE69204206D1 (de)	1995-09-28	Hydrodeziklierungsverfahren.
NO911430L (no)	1991-10-14	Stoffbehandlingsmetode.
ES1016723Y (es)	1992-08-01	Boligrafo-pulverizador mejorado.
FI923862A0 (fi)	1992-08-28	Anordning foer reducerad effektmatning.
DE69101652D1 (de)	1994-05-19	Behandlungsofen.
FI923486A0 (fi)	1992-07-31	Terapeutiska aemnen.
DE69203364D1 (de)	1995-08-17	Verbinder.
EP0605561A4 (en)	1995-04-12	ANNEXIN-XI.
DE69106733D1 (de)	1995-03-02	Fleischbehandlung.